salmeterol


Also found in: Dictionary, Acronyms, Wikipedia.
Related to salmeterol: Advair, salmeterol xinafoate, Seretide

salmeterol

 [sal-met´er-ol]
a beta2-adrenergic receptor agonist, used as s. xinafoate as an orally inhaled bronchodilator.

salmeterol

/sal·met·er·ol/ (sal-met´er-ol) a β agonist, used as s. xinafoate as a bronchodilator.

salmeterol

(săl-mē′tə-rôl′)
n.
An inhalant powder given in a salt form, C25H37NO4·C11H8O3, to treat and prevent bronchospasm in patients with asthma.

salmeterol

a sympathomimetic, long-acting bronchodilator.
indications It is prescribed in the maintenance treatment of reversible bronchospasm associated with asthma (including nocturnal asthma) and chronic obstructive pulmonary disease and to prevent exercise-induced asthma.
contraindications It should not be given to patients with allergy to any component of the drug formulation, when patients need a fast-onset inhaled beta-2 agonist for bronchodilation, or when patients have used MAO inhibitors within the past 2 weeks. The frequency of salmeterol administration should not be increased. Caution must be used when salmeterol is administrated to patients with conditions that have the potential to be exacerbated by sympathomimetic amines, including cardiovascular disease diabetes, prostatic hyperplasia, convulsions, thyrotoxicosis, and narrow-angle glaucoma.
adverse effects The side effects most often reported include changes in heart rhythm, muscle cramps or stiffness, parkinsonian-like symptoms, pallor, sweating, hives, and tingling of the skin.

salmeterol

A β2-adrenoceptor agonist used to control asthma and prevent high-altitude pulmonary edema

salmeterol

An adrenaline-like drug used to treat ASTHMA. A brand name is Serevent.
References in periodicals archive ?
Half of the children were given Salmeterol inhalers and half took Montelukast pills over the course of a year.
13 for combination, fluticasone only, salmeterol only, and placebo groups, respectively; p<0.
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
Many concerns have been raised that salmeterol may increase the risk of an asthma-related death.
Continued Therapy with Inhaled Corticosteroids in Patients with Persistent Asthma," and "Inhaled Corticosteroid Reduction and Elimination in Patients with Persistent Asthma Receiving Salmeterol.
This study does compare its results with those of other trials of salmeterol and fluticasone.
Those patients treated with the long-acting beta agonist were able to reduce the corticosteroid dose safely, but there was an unacceptably high rate of treatment failure in the salmeterol group when inhaled steroids were totally discontinued.
Scientists in Cleveland measured the power of inhaled salmeterol to prevent exercise-induced attacks in 20 people, averaging 29 years old, who had asthma.
For example, among patients with moderate to severe COPD, bronchial biopsies show that compared with placebo, the combination of fluticasone and salmeterol (a long-acting beta-agonist) has an anti-inflammatory effect at the cellular level, reducing numbers of macrophages, mast cells, and CD4 cells, among others (Am.
The inhaled corticosteroids evaluated were fluticasone, sold in combination with salmeterol as Advair, and budesonide, sold in combination with formoterol as Symbicort.
Fluticasone propionate/salmeterol (Advair) is a combination product of the corticosteroid fluticasone with the long-acting beta-agonist bronchodilator salmeterol.
The labels of three GlaxoSmithKline asthma products containing salmeterol now have boxed warnings citing a "small but significant increase in asthma-related deaths," based on recommendations from the Food and Drug Administration.